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Common Variants in the BMP2, BMP4, and HJV Genes
of the Hepcidin Regulation Pathway Modulate HFE
Hemochromatosis Penetrance
Jacqueline Milet,* Vale´rie De´hais,* Catherine Bourgain, Anne Marie Jouanolle, Annick Mosser,
Miche`le Perrin, Jeff Morcet, Pierre Brissot, Ve´ronique David, Yves Deugnier, and Jean Mosser
Most cases of genetic hemochromatosis (GH) are associated with the HFE C282Y/C282Y (p.Cys282Tyr/p.Cys282Tyr)
genotype in white populations. The symptoms expressed by C282Y homozygotes are extremely variable. Only a few
suffer from an overt disease. Several studies have suggested that, in addition to environmental factors, a genetic component
could explain a substantial part of this phenotypic variation, although very few genetic factors have been identified so
far. In the present study, we tested the association between common variants in candidate genes and hemochromatosis
penetrance, in a large sample of C282Y homozygotes, using pretherapeutic serum ferritin level as marker of hemochro-
matosis penetrance. We focused on two biologically relevant gene categories: genes involved in non-HFE GH (TFR2,
HAMP, and SLC40A1) and genes involved in the regulation of hepcidin expression, including genes from the bone
morphogenetic protein (BMP) regulatory pathway (BMP2, BMP4, HJV, SMAD1, SMAD4, and SMAD5) and the IL6 gene
from the inflammation-mediated regulation pathway. A significant association was detected between serum ferritin level
and rs235756, a common single-nucleotide polymorphism (SNP) in the BMP2 genic region ( ). Mean55Pp 4.42# 10
ferritin level, adjusted for age and sex, is 655 ng/ml among TT genotypes, 516 ng/ml in TC genotypes, and 349 ng/ml
in CC genotypes. Our results further suggest an interactive effect on serum ferritin level of rs235756 in BMP2 and a SNP
in HJV, with a small additive effect of a SNP in BMP4. This first reported association between common variants in the
BMP pathway and iron burden suggests that full expression of HFE hemochromatosis is linked to abnormal liver expression
of hepcidin, not only through impairment in the HFE function but also through functional modulation in the BMP
pathway. Our results also highlight the BMP regulation pathway as a good candidate for identification of new modifier
genes.
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Genetic hemochromatosis (GH) is a group of hereditary
disorders proceeding from an impairment in the produc-
tion of the key regulator of plasma iron, hepcidin,1 and
resulting in progressive iron loading of parenchymas. Four
recessive forms of GH are currently described.2 Two late-
onset, adult forms (HFE [MIM 235200] and HFE3 [MIM
604250]) are related to mutations in HFE (MIM 235200)
or TFR2 (MIM 604720), the gene encoding the receptor
transferring 2 protein. Two early-onset, juvenile forms (JH
[MIM 602390]) are secondary to mutations in either the
gene encoding hemojuvelin (HJV [MIM 608374]) or the
gene encoding hepcidin (HAMP [MIM 606464]). The “fer-
roportin disease” (HFE4 [MIM 606069]), related to mu-
tation in the SLC40A1 gene (SLC40A1 [MIM 604653]) cod-
ing for the metal-transporter ferroportin regulated by
hepcidin, is a closely related but not classic form of GH,
because of a dominant transmission usually with predom-
inant mesenchymal iron deposition.3
HFE hemochromatosis accounts for 195% of GH cases
in white populations.4 It is related to one major mutation,
C282Y, with a reported frequency of 5%–15%.5–7 The bi-
ochemical or clinical symptoms expressed by C282Y ho-
mozygotes are extremely variable.8 Only a few suffer from
an overt disease consisting of various associated symp-
toms, including osteoarticular damage, cirrhosis, diabet-
es, hypogonadism, arrhythmia, and heart failure. Most
C282Y homozygotes display a mild disease limited to bi-
ochemical abnormalities (increased transferrin saturation,
with or without elevated serum ferritin), with either ab-
sent or mild clinical symptoms. Moreover, some homo-
zygotes may show no expression throughout their lives.9
As a whole, estimates of the penetrance of C282Y ho-
mozygosity by studies have ranged from 1% to 90%.5,10–
13 This wide range reflects the variability in the definition
of disease penetrance, with some studies referring to the
level of iron burden (serum ferritin, liver iron concentra-
tion…) using disparate thresholds, others to organ dam-
age, and most to mixed criteria. These results are com-
plicated by the absence of a strict correlation between the
level of iron burden and organ-damage expression. How-
Table 1. Single SNP Genotypic and Allelic Association with Ferritin Level for All 75 SNPs
Gene (Chromosome) and SNP
Location
(bp) MAF
Pa for Association Test
Allele (Frequency) Associated
with Higher Ferritine LevelGenotypic Allelic
HAMP (19):
rs916145 40,459,724 .113 .7637 .5016
rs10405246 40,460,789 .221 .1045 .0423 A (.779)
rs1882694 40,463,222 .376 .3376 .1576
rs7251432 40,467,281 .491 .8527 .5838
rs12971321 40,471,262 .376 .8367 .9815
rs10402233 40,472,691 .347 .2110 .1180
rs17705188 40,473,156 .084 .9412 .8520
BMP2 (20):
rs2206917 6,683,511 .434 .9867 .9516
rs235730 6,684,189 .418 .9146 .9172
rs6077060 6,688,317 .099 .1262 .0498 T (.099)
rs235710 6,688,366 .439 .5832 .3072
rs1980499 6,694,498 .495 .5092 .3742
rs3178250 6,708,201 .173 .4460 .2532
rs235772 6,710,719 .409 .2757 .1124
rs6117432 6,712,536 .233 .9039 .6946
rs173107 6,713,841 .380 .0026 .0052 T (.380)
rs235757 6,714,019 .374 .1994 .0933
rs235756 6,715,111 .364 1.80 # 104 4.42 # 105 T (.636)
rs910141 6,715,642 .255 .0038 .0010 G (.745)
rs235753 6,717,533 .348 .2473 .0950
rs6054514 6,719,370 .052 .4355 .4865
rs235704 6,720,263 .120 .9306 .7748
rs17804639 6,721,316 .092 .5071 .3447
BMP4 (14):
rs10498464 53,441,332 .193 .3857 .2666
rs1951865 53,442,591 .372 .5052 .5954
rs11157990 53,453,695 .303 .3464 .1881
rs3742555 53,455,219 .058 .1838 .0760
rs2147105 53,475,815 .448 .7883 .5060
rs4444235 53,480,669 .492 .1852 .6077
rs762642 53,492,803 .409 .7235 .5443
rs1957860 53,499,105 .467 .8738 .8229
rs6572927 53,503,140 .081 .2345 .1097
rs11157994 53,521,052 .076 .0766 .1883
rs1957844 53,527,828 .230 .1068 .5648
rs4901474 53,539,487 .429 .0050 .0054 C (.429)
HJV (1):
rs16827043 144,106,797 .102 .8254 .9153
rs7536827 144,109,299 .452 .9444 .8876
SMAD1 (4):
rs6537355 146,622,042 .149 .2329 .7810
rs2118438 146,647,834 .187 .1893 .0839
rs714195 146,665,130 .408 .9119 .7041
rs1016792 146,698,229 .200 .3142 .1397
rs2036138 146,704,312 .467 .7503 .8810
rs11939979 146,707,777 .469 .6741 .7925
SMAD4 (18):
rs606073 46,749,479 .440 .3876 .7981
rs10163789 46,749,360 .070 .7042 .7042
rs10502913 46,822,269 .269 .9241 .9260
rs17663887 46,843,716 .098 .5783 .3150
rs17663994 46,920,796 .329 .3553 .8460
rs9304408 46,928,354 .362 .0510 .3874
rs9963878 46,933,520 .089 .1652 .0655
rs7242459 46,935,348 .396 .6693 .3740
SMAD5 (5):
rs2346361 135,476,404 .459 .2769 .2209
rs9327744 135,501,661 .236 .4137 .2589
TFR2 (7):
rs7812235 100,049,422 .195 .5966 .3716
rs10247962 100,057,865 .155 .2861 .7993
rs4434553 100,078,127 .492 .0920 .0315 G (.492)
(continued…)
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Table 1. (continued)
Gene (Chromosome) and SNP
Location
(bp) MAF
Pa for Association Test
Allele (Frequency) Associated
with Higher Ferritine LevelGenotypic Allelic
SLC40A1 (2):
rs12693541 190,126,935 .134 .1990 .0757
rs11884632 190,133,087 .244 .6722 .4917
rs2304704 190,138,422 .354 .1747 .1206
rs10188230 190,140,858 .020 .3613 .3698
rs16831659 190,141,534 .103 .2471 .1823
rs10202029 190,154,529 .025 .0677 .0677
rs2352267 190,157,210 .395 .7741 .4807
rs1123109 190,162,978 .208 .8950 .6928
IL6 (7):
rs1880242 22,726,132 .494 .4962 .8671
rs10499563 22,727,013 .238 .2078 .0782
rs2056576 22,727,727 .307 .2417 .0924
rs12700386 22,729,534 .177 .4979 .5244
rs2069827 22,731,981 .106 .8888 .6857
rs1800795 22,733,170 .441 .9075 .7436
rs2069837 22,734,552 .068 .2151 .0796
rs2069840 22,735,097 .344 .8775 .6220
rs2069860 22,737,563 .088 .2467 .1021
rs2069849 22,737,681 .007 .0051 .0051 T (.007)
rs2069861 22,738,179 .018 .3537 .3537
a P value uncorrected for multiple testing.
ever, they strongly support the involvement of factors
modulating disease expressivity. With respect to iron load-
ing, environmental factors have been poorly investigated
in humans, although it is likely that some may be relevant,
such as alimentary regimen and blood donation.11 Several
results also suggest the role of additional genetic factors.
The incidence of GH-related conditions is higher in rel-
atives of clinically affected probands than in relatives of
probands with only elevated transferrin saturation,14 and
concordance of iron store indices in GH-affected families
between same-sex siblings homozygous C282Y is high.15
On the basis of a twin study, Whitfield et al.16 estimated
that HFE explains only part of the genetic component of
iron-store variation. In mice, differences in hepatic iron
loading in two Hfe-deficient mice strains have been as-
sociated with a polygenic pattern of inheritance.17
Apart from sex, only a few genetic factors have been
identified as putatively modifying disease expression. A
mitochondrial polymorphism was reported as more fre-
quent in C282Y homozygotes with hemochromatosis
than in nonexpressing C282Y homozygotes.18 However,
in another study, no association has been observed be-
tween the ferritin level of C282Y homozygotes and the
same polymorphism.19 Mutations in two other genes in-
volved in iron metabolism, HJV and HAMP, have been
clearly associated with higher iron indices in a French
cohort of C282Y homozygotes,20–22 but the mutations
identified are rare, with a frequency of heterozygous car-
riers !2% among C282Y homozygotes.
Hepcidin is a peptide hormone produced by the liver
that controls plasma iron concentration and iron-tissue
distribution by inhibiting intestinal iron absorption, iron
recycling by macrophages, and iron mobilization from the
liver. Interestingly, hepcidin levels are abnormally low in
patients with adult or juvenile forms of GH. Babitt et al.23
recently demonstrated that hepcidin expression is in-
duced by the bone morphogenetic protein (BMP)–signal-
ing pathway. This pathway involves BMP2 and BMP4 pro-
teins and the BMP coreceptor HJV, which phosphorylates
receptor-activated Smad proteins (R-Smads) 1 and 5. Phos-
phorylated R-Smads form a complex with the common
mediator Smad4 (Co-Smad), which allows signal trans-
duction into the nucleus for hepcidin gene induction.
The aim of the present study was to search for relatively
frequent variants (as opposed to the rare mutations al-
ready known) in genes that modify the serum ferritin lev-
els in C282Y homozygotes. Given these recent molecular
data, we focus on variants in two pathophysiologically
relevant gene categories: genes involved in non–HFE he-
mochromatosis and genes involved in the regulation of
hepcidin expression. In a large sample of C282Y homo-
zygotes, we tested for association between initial serum
ferritin levels and SNPs located within or near 10 genes:
3 non–HFE-GH genes (TFR2, HAMP, and SLC40A1), 6 BMP
signaling pathway genes (BMP2 [MIM 112261], BMP4
[MIM 112262], HJV, SMAD1 [MIM 601595], SMAD4 [MIM
600993], and SMAD5 [MIM 603110]), and the IL6 gene
(IL6 [MIM 147620]) coding for an inflammatory cytokine
known to increase inflammation-mediated hepcidin ex-
pression. We detected a significant association between a
SNP in the BMP2 genic region and serum ferritin level,
adjusted for age and sex. Given the biologically relevant
gene interactions along the BMP regulatory pathway, our
data suggest an additive effect on serum ferritin level of
the BMP2 SNP and of a SNP in BMP4, with an interaction
effect between the BMP2 SNP and a SNP in HJV.
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Table 2. Haplotype Association with
Ferritin Level
Gene
No. of SNPs
in the Gene
Global
Pa
Genes with !10 SNPs:
HJV 2 .951
SMAD1 6 .571
SMAD4 8 .792
SMAD5 2 .516
HAMP 7 .106
SLC40A1 8 .290
TFR2 3 .128
Genes with 110 SNPsb:
BMP2 5 .0098
BMP4 5 .052
IL6 5 .013
a Global P values obtained by permutation are
not corrected for multiple testing across genes but
are corrected for the number of SNPs included in
each haplotype.
b Global P value for the best five-SNP combina-
tion (BMP2, rs235756 to rs235704; BMP4, rs762642
to rs1957844; IL6, rs12700386 to rs2069840).
Figure 1. LD ( ) between SNPs of the BMP2 gene2r
The database of the Family Screening Centre for He-
mochromatosis8 comprises all C282Y homozygous pro-
bands referred to the Liver Unit in Rennes, France, since
1990 and their relatives who received diagnoses through
a systematic family-screening policy. At the time of the
study, 1,319 C282Y homozygotes were recorded, among
whom 729 unrelated probands fulfilled inclusion criteria:
availability of (i) sex, (ii) age at diagnosis, (iii) serum fer-
ritin level at diagnosis before any venesection therapy, and
(iv) DNA sample stored at 20C. Of these 729 subjects,
592 gave their written informed consent to participate in
the study, in accordance with the protocol validated by
the committee of ethics of Rennes on November 10, 2004.
Of these 592 subjects, 262 were women and 330 were
men. Mean (SD) age was 46 (14) years for women and 44
(13) years for men. Median value (25th–75th percentile
range) for ferritin levels was 1,040.5 ng/ml (582–2,356) in
men and 400.5 ng/ml (186–699) in women. Ferritin data
were normalized using a loge transformation. Log-trans-
formed ferritin levels were adjusted for age, with consid-
eration of age groups of 10 years, and sex. The final mul-
tiple-regression model includes a parameter for each of
the seven independent age groups, a parameter for sex,
and an interaction parameter, Age # Sex, for each age
group.
Genomic DNA was extracted from peripheral blood cells
by the phenol-chloroform method or by use of the Flex-
igen DNA kit (Qiagen). SNPs in the 10 candidate genes
were selected from the CEU HapMap database. For each
gene, a region including the complete genic sequence and
the upstream and downstream intergenic sequences was
delimited. The set of tag SNPs was identified for each re-
gion, so that all the SNPs with a minor-allele frequency
(MAF) 5% in the database have a pairwise with2r  0.8
at least one tag SNP. Tagging was performed using the
algorithm implemented in Tagger.24 Two coding SNPs lo-
cated within the IL6 gene were added to the list. A total
of 81 SNPs were included in the study.
SNP genotyping followed Custom SNP Genotyping As-
says consisting of a mix of unlabeled PCR primers and
TaqMan minor groove binder (MGB) SNP-allele-specific
probe. PCR primers and probes used for allelic discrimi-
nation were designed and purchased from the Applied
Biosystems “assay on demand” or “assay by design.” Ge-
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Table 3. Comparison between Models of Gene Combinations Implicated in the Regulation of Hepcidin
Expression
Model and Gene Combination
P Value of Model versus
Null
Model
No
Interaction M1a M2a M3b M4
M1:
BMP2 4.42 # 105 … … … … …
M2:
BMP2BMP4 1.68 # 106 … .0031 … … …
BMP2BMP4BMP2#BMP4c 6.10 # 106 .550 … … … …
M3:
BMP2HJV 2.19 # 104 … .923 … … …
BMP2HJVBMP2#HJV 1.64 # 105 .0046 .0179 … … …
M4:
BMP2BMP4HJVBMP2#HJV 8.41 # 107 … .0013 .0153 .0046 …
M5:
BMP2BMP4HJVBMP2#HJVSMAD 4.46 # 107 … .0021 .0135 .0070 .0708
BMP2BMP4HJVBMP2#HJVSMAD BMP2#SMADc 7.93 # 107 .281 … … … …
a Models without interaction.
b Model including interaction term.
c Interaction not significant. Model not contrasted with simpler models.
notyping followed the Applied Biosystems protocol.
Briefly, PCR was performed in a final volume of 5 ml con-
taining 10 ng of sample DNA, 0.625 ml of custom SNP-
specific Assay Mix, and 2.5 ml of Universal Master Mix no
AmpErase UNG. Amplification was allowed to proceed for
40 cycles of 15 s at 95C and 60 s at 60C. Automatic
genotype call was performed !24 h after PCR, by scanning
microtitration plates on the 7900HT Fast Real-Time PCR,
which provides the SDS2.3 software (Applied Biosystems).
Assays for rs1880241 (in IL6) and rs6596286 (in SMAD5)
were unsuccessful. Of the 79 SNPs genotyped, 4 SNPs
(rs1005464 in BMP2, rs10498466 and rs4901473 in BMP4,
and rs3764942 in SMAD5) were not in Hardy-Weinberg
equilibrium and therefore were excluded from the anal-
yses. Mean genotyping success rate for the 75 remaining
SNPs was 99.1%. Correlation between allele frequencies
of the 75 SNPs in our sample and allele frequencies in the
CEU HapMap data was very high (regression ).2r p 0.94
The linkage disequilibrium (LD) structure among SNPs
was examined with Haploview.25 The mean between our2r
markers, computed on the whole sample, was 0.10. All
subsequent statistical analyses were performed using R.26
A linear regression was used to test for association between
each individual SNP and ferritin. Both allelic and geno-
typic associations were considered. The sensitivity of as-
sociation results to the inclusion of phenotypic outliers
was evaluated. Because the results were fully concordant,
we present and discuss only results based on the whole
sample. To correct for multiple testing, the effective num-
ber of independent tests was assessed using the method
of Li and Ji27 as implemented in the SNPSpd software.28
Following this procedure, our set of 75 SNPs is equivalent
to 62 independent tests. When a Bonferroni correction is
applied, an individual significance threshold of 48# 10
should be used to control a global 5% type I error.
Association between haplotypes and ferritin was tested
using the efficient score statistic proposed by Schaid et
al.29 and implemented in haplo.stats R-Package v1.2.2
(Schaid Lab Web site) with a permutation-based assess-
ment of the P values. We favored this relatively simple
regression-based approach over more sophisticated ones
based on population history modeling,30 because our sam-
ple is a subsample selected from the general population
with an unknown selection scheme. In the absence of a
clear evaluation of the consequences of such a selection
scheme on sophisticated haplotype tests, we favored a ro-
bust approach.31 Haplotypes comprising all SNPs were
considered for genes with !10 SNPs. Otherwise, haplo-
types comprising five SNPs were considered, with a sliding
window of one SNP to browse the gene. Sensitivity to
window size was evaluated. Because results were fully con-
cordant, we present and discuss only results based on five-
SNP windows. Association of SNP combinations within
genes was further analyzed using unphased, multimarker
data. A stepwise linear regression starting from the model
including only the SNP with the lowest individual P value
was performed to determine the subset of SNPs with the
strongest association.
In a final, exploratory stage, we evaluated the associa-
tion of several biologically relevant gene combinations
with ferritin level. To limit the number of combinations
tested, we considered only those for which a molecular
interaction between gene products has been described and
which include one gene showing significant association
at the single-gene level. Again, we used multiple-regres-
sion models. To evaluate whether more-complex models
were significantly better predictors of phenotype than
simpler ones, we compared nested models (simpler models
are particular cases of the more complex models) using F
statistics. These results are exploratory, in the sense that
we drop the requirement for multiple-comparison adjust-
ment while assessing significance. For each gene combi-
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Table 4. Genotype Frequencies and Counts for the Three
SNPs Best Explaining the Ferritin Level (rs235756 in BMP2,
rs4901474 in BMP4, and rs16827043 in HJV )
BMP2 Genotype
(Frequencya) and
HJV Genotype
Frequencya (n)
BMP4 # BMP2 # HJV
for BMP4 Genotype
BMP2 # HJV C/C T/C T/T
T/T (40.4, ):np 237
A/A 33.7 (198) 6.0 (35) 16.2 (95) 11.6 (68)
A/G  G/G 6.6 (39) 1.2 (7) 3.6 (21) 1.9 (11)
T/C (46.5, ):np 273
A/A 37.0 (217) 8.0 (47) 16.4 (96) 12.6 (74)
A/G  G/G 9.5 (56) 1.4 (8) 4.3 (25) 3.9 (23)
C/C (13.1, ):np 77
A/A 10.2 (60) 1.2 (7) 6.3 (37) 2.7 (16)
A/G  G/G 2.9 (17) 1.2 (7) 1.2 (7) .5 (3)
a Genotype frequencies calculated for the 587 individuals fully ge-
notyped for the three polymorphisms.
Figure 2. Mean ferritin levels at diagnosis, adjusted for age and sex, in the different BMP2, HJV, and BMP4 genotype categories. A,
Means classified by rs235756 genotype (BMP2). B, Means classified by both rs235756 (BMP2) and rs16827043 (HJV) genotypes with
pooling of the A/G and G/G genotypic categories for the latter. C, Means classified by rs235756 (BMP2), rs16827043 (HJV) and rs4901474
(BMP4) genotypes. Mean values are reported in panels A and B but have been omitted for the sake of clarity in panel C. 95% variation
intervals are reported as vertical bars.
nation, a “best model” was estimated with a backward
regression, starting from a full model that included the
three SNPs displaying the strongest individual association
for each gene and two SNP-interaction terms.
SNP rs235756, located in the 3′ region of BMP2, is sig-
nificantly associated with ferritin level in our C282Y ho-
mozygote sample (table 1), after correction for multiple
testing (uncorrected ; corrected ).5Pp 4.4# 10 Pp .002
Note that the association would still have been significant
if a more conservative Bonferroni correction for 75 tests
had been applied (corrected P value would then be .003).
The T allele associated with higher ferritin level has a fre-
quency of 0.64 (HapMap CEU frequency is 0.58). Mean
ferritin level, adjusted for age and sex, is 654.66 ng/ml
among TT genotypes, 516.39 ng/ml among TC genotypes,
and 349.11 ng/ml among CC genotypes. A neighboring
SNP in the gene (rs910141) also displays a suggestive as-
sociation (corrected ), but rs235756 and rs910141Pp .062
are in LD ( ), as can be seen from figure 1. In-2r p 0.528
terestingly, SNP rs235756 has no impact on the age at
diagnosis (mean age at diagnosis, adjusted for sex, is 44.7
years among TT genotypes, 45 years among TC genotypes,
and 45.8 years among CC genotypes; P value of the anal-
ysis of variance [ANOVA] is .82). Suggestive but nonsig-
nificant associations are also observed for one SNP in
BMP4 (rs4901474, uncorrected , correctedPp .0054 Pp
) and one synonymous SNP in IL6 (rs2069849; un-.335
corrected , corrected ). Because the re-Pp .0051 Pp .316
sults for the allelic and the genotypic tests were very sim-
ilar, the following analyses were performed considering
the allelic model only.
Results for haplotype association are presented in table
2. In BMP2, the best haplotype combination provided a
P value of only .0098, which did not improve the single-
SNP association. Similar results were observed for BMP4
and IL6. Tests based on unphased genotype data did not
detect any additional interesting SNP combination (results
not shown). However, the tagging strategy chosen leads
to a low LD among SNPs in each gene (mean ), a2r p 0.1
situation in which multimarker approaches (either phased
or unphased) are expected to be less powerful.32
As BMP2 was the only gene found significantly associ-
ated with ferritin in the previous analyses, we focused on
the hepcidin expression-regulation pathway to explore
possible effects of gene combinations. Analyses of gene
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combinations were restricted to biologically relevant com-
binations, including BMP2. Four combinations were an-
alyzed: BMP2 and BMP4 (molecular interaction of the two
BMP proteins); BMP2 and HJV (molecular interaction of
HJV and BMP2); BMP2, BMP4, and HJV (molecular inter-
action); and BMP2, BMP4, HJV, SMAD1, SMAD4, and
SMAD5 (genes implicated in the whole BMP-signaling
pathway). The three most-associated SNPs (in the single-
SNP analyses) for each gene were potentially included in
the models, as well as interactions involving SNPs from
BMP2. Starting from the simple M1 model, in which only
rs235756 is included, table 3 presents the comparison with
more-complex models of gene combinations, expressed as
P values of model comparison tests. Models M2, M3, M4,
and M5 correspond to the “best models” of the gene com-
bination considered. In our case, the best M2, M3, and
M4 models included only one SNP per gene (M2, rs235756
in BMP2 and rs4901474 in BMP4; M3, rs235756 in BMP2
and rs16827043 in HJV; M4, rs235756 in BMP2, rs4901474
in BMP4, and rs16827043 in HJV). In model M5, only one
SNP in SMAD4 remained (rs235756 in BMP2, rs4901474
in BMP4, rs16827043 in HJV, and rs9963878 in SMAD4).
Interestingly, an additive effect of BMP4 and BMP2 was
detected (M1 vs. M2 comparison ), as well as anPp .0031
interaction between BMP2 and HJV (M1 vs. M3 compar-
ison ). These two effects added up, so that thePp .0179
model best explaining the ferritin level (model 4) included
an interaction between BMP2 (SNP rs235756) and HJV
(SNP rs16827043) and an additive effect of BMP4 (SNP
rs4901474) (M2 vs. M4 comparison ). IncludingPp .0153
SNPs from the SMAD genes did not improve the associa-
tion (M4 vs. M5 comparison ). Figure 2 presentsPp .071
the ferritin levels, adjusted for age and sex, in the different
BMP2, HJV, and BMP4 genotype categories, and table 4
presents the frequencies of these three SNP genotype cat-
egories in our sample. The interaction effect of BMP2 and
HJV was such that the two-locus genotype combination
at greater risk (TT at rs235756 and A/G or G/G at rs162703)
involved the same HJV genotypes as the two-locus ge-
notype combination at lower risk (AA at rs235756 and A/
G or G/G at rs162703). Again, no effect of this gene com-
bination on age at diagnosis was detected.
In this study, we report the first association between
relatively common variants in genes of the BMP pathway
and iron burden, considering the pretherapeutic serum
ferritin level as a marker of hemochromatosis penetrance.
Although it may lead, in a given patient, to overestimate
iron burden in case of associated excessive alcohol con-
sumption, metabolic syndrome, or inflammation, it is a
good marker of body iron stores in large populations.33
Hepatic iron concentration, determined on liver biopsy,
or the amount of iron removed to obtain low body iron
stores would have been better markers, but such data are
difficult to reliably obtain for all subjects from a large
population.
Our sample of C282Y homozygotes from the Family
Screening Centre is not strictly representative of the pop-
ulation of C282Y homozygotes. It is rich in individuals
with serious symptoms. Conducting an association study
on such a selected sample tends to lower the power to
detect genetic factors modifying the effect of C282Y. How-
ever, the phenotypic variation in our sample seems to be
large enough to detect the effect of genetic variants. Note
that the associated allele of SNP rs235756 in BMP2 has a
frequency slightly higher in our sample (0.64) than in the
HapMap CEU sample (0.58), as would be expected for an
associated allele in a sample rich in extreme phenotypes.
Note also that the mean ferritin levels estimated for the
different genotypic categories are specific to our sample
and would only be biased estimates of the levels in the
whole C282Y homozygous population. The initial target-
ing of the biologically relevant BMP signaling pathway is
definitively key to our results. By narrowing the sets of
gene tested, we increased our power to detect the asso-
ciation, counterbalancing the inevitable limits of a se-
lected database with an indirect marker of penetrance.
In this association study, we used a tag SNP strategy in
which only a subset of SNPs, representative of the com-
mon polymorphism variability, were tested. This strategy
enabled us to fully cover the genes selected and the genic
regions upstream and downstream of the genes with re-
spect to SNP information available in the HapMap data-
base. However, association results should be interpreted
cautiously. A direct effect of SNP rs235756 on ferritin level
cannot be ruled out. But this polymorphism with no evi-
dent biological role on ferritin level is more likely a proxy
for one or several functional polymorphisms in the region,
yet to be identified.
Our results further suggest a possible additive effect be-
tween rs235756 in BMP2 and rs4901474 in BMP4. This
effect is particularly interesting, because both proteins are
able to activate the regulatory pathway and subsequent
hepcidin expression. Further, the interaction effect be-
tween rs16827043 in HJV and rs235756 in BMP2 is in line
with the biological demonstration that BMP2 exhibits
more affinity for HJV than BMP4 does.23
Further studies will also be necessary to evaluate
whether SNP rs235756 (or the functional polymorphism
for which rs235756 is a proxy) has an additive effect on
the C282Y homozygote genotype or a specific modifying
effect. Testing the effect of SNP rs235756 on serum ferritin
level in the general population should help with deci-
phering the model. An additive effect of rs235756 should
also be detected in the general population, whereas a spe-
cific modifying effect should not (the effect of rs235756
is restricted to C282Y homozygotes).
This first association between relatively common vari-
ants in genes of the BMP pathway and iron burden sug-
gests that full expression of HFE hemochromatosis is
linked to abnormal liver expression of hepcidin, not only
through impairment in the HFE function but also through
functional modulation in the BMP pathway. These results
support the idea that all the genes currently described in
the BMP signaling pathway are good candidates as mod-
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ifier genes in C282Y homozygotes. This includes BMP9
(GDF2 [MIM 605120]), because Truska et al.34 recently
showed that the liver-specific BMP9 is the most potent
inducer of hepcidin expression through the BMP pathway
in mouse, but also includes SMAD8 and BMP type I and
type II (BMPR1A [MIM 601299], BMPR1B [MIM 603248],
and BMPR2 [MIM 600799]) receptors.23 With respect to
other, non-HFE hemochromatosis genes and the IL6 gene,
no strong SNP association was observed in our patients,
which is in accordance with the findings of Truska et al.34
that TFR2 and IL6 act independently of the BMP pathway
to regulate hepcidin expression. However, the lack of as-
sociation with IL6 alone does not exclude the involvement
of other genes from the inflammation-mediated hepcidin
regulation pathway, including STAT335,36 (MIM 102582).
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Web Resources
The URLs for data presented herein are as follows:
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi
.nlm.nih.gov/Omim/ (for HFE, HFE3, HFE, TFR2, JH, HJV,
HAMP, HFE4, SLC40A1, BMP2, BMP4, SMAD1, SMAD4, SMAD5,
IL6, GDF2, BMPR1A, BMPR1B, BMPR2, and STAT3)
Schaid Lab Web site, http://mayoresearch.mayo.edu/mayo/
research/schaid_lab/software.cfm?CFIDp7459420&CFTOKEN
p67925359 (for haplo.stats software)
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